Dr. Gordon Louis Grado, MD

  • Scottsdale, AZ
  • Radiation oncologist
NPI1225092745PAC ID4587576988
Medicare services, 2024
5,382
Medicare patients, 2024
372
Part D claims, 2024
766
Publications
11
Clinical trials
1
Practice address
2926 N Civic Center Plz, Scottsdale, AZ 85251
Practice phone
Call (480) 614-6300
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Southwest Oncology Centers

Scottsdale, Arizona

See all 9 affiliations

Find Dr. Grado's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Gordon Louis Grado is a radiation oncologist in Scottsdale, Arizona

Dr. Grado practices at Southwest Oncology Centers in Scottsdale, Arizona.

Dr. Grado's NPI, 1225092745, was assigned on April 13, 2006. Dr. Grado graduated from SIU School of Medicine in 1977. Dr. Grado's Arizona license number on file is 17487.

NPI and contact details
Medicare PAC ID
4587576988
NPI enumeration date
April 13, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(480) 614-6300
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
75
Medical school graduation
1977

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Gordon Louis Grado practices at Southwest Oncology Centers in Scottsdale, Arizona

Dr. Grado's primary practice is Southwest Oncology Centers, at 2926 N Civic Center Plz, Scottsdale, AZ 85251 in Maricopa County. The practice phone is (480) 614-6300.

  • Southwest Oncology Centers
    2926 N Civic Center Plz, Scottsdale, AZ 85251 · Maricopa CountyPhone(480) 614-6300

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Gordon Louis Grado is affiliated with 7 sites of care and 2 medical groups

Dr. Grado's primary practice is Southwest Oncology Centers in Scottsdale, Arizona. Dr. Grado is also affiliated with HonorHealth Scottsdale Shea Medical Center. The medical group on file is Southwest Oncology Centers. Dmand AI also links Dr. Grado to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

See all 9 affiliations for Dr. Grado

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Gordon Louis Grado's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grado practices, 6 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Southwest Oncology CentersAvailable with a free account
+6 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Grado practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Gordon Louis Grado is one of 141 radiation oncologists in Arizona

Radiation oncology is Dr. Grado's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Grado is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Grado's licenses on file in 8 states: Arizona, Iowa, Hawaii, Illinois, Minnesota, North Dakota, New Mexico and Washington.

Specialties and state licenses

  • Radiation oncology, ArizonaPrimaryLicense 17487 · 1988 to 2025 · taxonomy 2085R0001X
  • Iowa license1982 to 2027
  • Hawaii license2003 to 2026
  • Illinois license1978 to 2026
  • Minnesota license1979 to 2026
  • North Dakota license2025 to 2026
  • New Mexico license1999 to 2025
  • Washington license1997 to 2021

Clinical focus

Dmand AI lists anal cancer radiation, bladder cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation and lung cancer radiation among the conditions Dr. Grado treats.

Radiation oncologists near Dr. Grado

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Gordon Louis Grado billed Medicare for 5,382 services in 2024

CMS data shows 5,382 Medicare services from Dr. Grado across 30 procedure codes in 2024, for 372 Medicare patients. Medicare paid $875,408 for them.

Medicare services, 20245,382
Medicare patients372
Paid by Medicare$875,408
Procedure codes30

Dr. Grado's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Imaging
2023: 2,4482024: 2,5986%
Other services
2023: 1,4462024: 1,91532%
Office and hospital visits
2023: 7712024: 69310%
Drugs given in the office
2023: 1592024: 9640%
Surgery
2023: 332024: 6082%
Tests and treatments
2023: 252024: 2020%

Where Dr. Grado's Medicare services took place, 2024

  • In an office5,21097%
  • In a facility1723%

Dr. Grado compared with the Arizona median for radiation oncologists, 2024

  • Dr. Grado
  • Arizona median
Medicare services
5,382vs 2,0722.6 times
Medicare patients
372vs 22863% above
Part D claims
547vs 4412.4 times

Medians across 141 radiation oncologists in Arizona with Dmand AI profiles that report each measure.

Dr. Grado's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Grado

Need commercial claims for Dr. Grado?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Grado and other radiation oncologists in Arizona.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Gordon Louis Grado treated 372 Medicare patients in 2024, average age 76

CMS counts 372 Medicare patients who saw Dr. Grado in 2024. The largest group is 75 to 84, with 166 patients. 75% of them have cancer, and 74% have high cholesterol. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Grado's median patient age at 74, with 15% women.

Medicare patients, 2024372
Average age76
Average risk score1.45

Dr. Grado's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Grado's Medicare patients by sex, 2024

  • Women5515%
  • Men31785%

Chronic conditions among Dr. Grado's Medicare patients, 2024

  1. Cancer75%
  2. High cholesterol74%
  3. High blood pressure68%
  4. Ischemic heart disease42%
  5. Arthritis38%
  6. Atrial fibrillation19%
  7. Chronic kidney disease19%
  8. Diabetes19%

Share of Medicare patients with each condition. A patient can have several.

Dr. Grado's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 74

Patient panel by sex, all payers

  • Women15%
  • Men85%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Gordon Louis Grado wrote 766 Medicare Part D claims in 2024

In 2024, Dr. Grado wrote 766 Medicare Part D claims for 232 patients. 97% of them were for generic drugs. CMS names the drug for 547 of them, across 9 drugs with 11 or more claims each, at $9,644 in total drug cost. In 2023, CMS named 450 claims across 8 drugs.

Part D claims, 2024766
Drugs named by CMS9
Total drug cost$9,644
Part D patients232

Dr. Grado's Part D claims by kind of drug, 2024

  • Generic741 claims97%
  • Brand-name and other25 claims3%

Dr. Grado's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Grado's Part D claims, 2024

  • Opioids8%63 of 766 claims
  • Antibiotics17%128 of 766 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 4502024: 54722%

Drugs named by CMS: 9 in 2024, 8 in 2023.

See all prescribing by Dr. Grado

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Gordon Louis Grado offers telehealth to Medicare patients

Dr. Grado accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Grado as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find radiation oncologists like Dr. Grado by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Gordon Louis Grado has 11 publications on record

Dmand AI links 11 papers to Dr. Grado in 2010. The most frequent topics are Carcinoma, Squamous Cell, Radiotherapy and Actuarial Analysis. Dr. Grado has published most often in Mayo Clin Proc. Dr. Grado's most frequent co-authors are Steven Buskirk, MD, Harish Gangaram Ahuja, MD and William James Maples, MD.

Papers11

Topics Dr. Grado writes about most

  • Carcinoma, Squamous Cell
  • Radiotherapy
  • Actuarial Analysis
  • Brachytherapy
  • Carcinoma in Situ
  • Laryngeal Neoplasms
  • Prostatic Neoplasms
  • Radiotherapy Dosage

Dr. Grado's most frequent co-authors

Recent publications by Dr. Grado

See all 11 publications and co-authors

See who Dr. Grado researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Grado works with, so you can find a warm path to the right radiation oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Gordon Louis Grado has worked on 1 clinical trial

Dmand AI links Dr. Grado to 1 clinical trial. Conditions studied include Carcinoma, Basal Cell and Neoplasms, Basal Cell.

Conditions in Dr. Grado's trials

  • Carcinoma, Basal Cell
  • Neoplasms, Basal Cell

Investigators on the most trials with Dr. Grado

Recent clinical trials with Dr. Grado

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Gordon Louis Grado received $14,147 in industry payments from 2016 to 2025

CMS Open Payments shows 283 general payments to Dr. Grado from 61 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 54% of the total. Novocure Inc. paid the most, $3,898.

General payments to Dr. Grado by program year, 2016 to 2025

General payments to Dr. Grado by kind, 2016 to 2025

$14.1Kin total
  • Food and beverage$7,65554%
  • Honoraria$3,60025%
  • Travel and lodging$2,54318%
  • Education$3492%

Companies that paid Dr. Grado the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Grado

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Gordon Louis Grado has 3 awards and honors on record

Dmand AI lists 3 awards for Dr. Grado, most recently America's Top Doctors in 2014.

Awards and honors for Dr. Grado

  1. 2014
    • America's Top Doctors
  2. 2013
    • America's Top Doctors for Cancer
    • Top Doctors:Arizona State

Source: Dmand AI Professional Profile Data

Dr. Gordon Louis Grado graduated from SIU School of Medicine

Dr. Grado graduated from SIU School of Medicine in 1977. Dr. Grado is a member of ASCO.

  1. Medical schoolSIU School of Medicine
  2. Board certified in radiation oncologyAmerican Board of Radiology

Source: Dmand AI Professional Profile Data

Dr. Gordon Louis Grado accepts plans from 17 insurance carriers

Dr. Grado is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

Plan types Dr. Grado accepts, by number of carriers

  1. PPO9
  2. HMO8
  3. Medicare6
  4. POS5
  5. EPO4
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Gordon Louis Grado's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Gordon Louis Grado

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Gordon Louis Grado's NPI number?

Dr. Gordon Louis Grado's NPI number is 1225092745. It was assigned on April 13, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Gordon Louis Grado?

Dr. Gordon Louis Grado is a radiation oncologist in Scottsdale, Arizona. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. Gordon Louis Grado practice?

Dr. Grado practices at 2926 N Civic Center Plz, Scottsdale, AZ 85251. Dr. Grado's primary practice is Southwest Oncology Centers in Scottsdale, Arizona. Dmand AI also links Dr. Grado to 4 hospitals, 1 group practice or clinic and 1 medical group.

What is Dr. Gordon Louis Grado's office phone number?

The practice phone on file for Dr. Grado is (480) 614-6300.

What is Dr. Gordon Louis Grado's medical license number?

Dr. Grado's Arizona license number on file is 17487, one of the licenses on file in 8 states.

Which states has Dr. Gordon Louis Grado been licensed in?

Dmand AI has state licenses on file for Dr. Grado in Arizona (1988 to 2025), Iowa (1982 to 2027), Hawaii (2003 to 2026), Illinois (1978 to 2026), Minnesota (1979 to 2026), North Dakota (2025 to 2026), New Mexico (1999 to 2025) and Washington (1997 to 2021).

Which hospitals is Dr. Gordon Louis Grado affiliated with?

Dr. Grado is affiliated with HonorHealth Scottsdale Shea Medical Center. Dmand AI links Dr. Grado to 4 more hospitals.

What medical group is Dr. Gordon Louis Grado part of?

Dr. Grado is linked to Southwest Oncology Centers. Dmand AI links Dr. Grado to 1 more medical group.

Does Dr. Gordon Louis Grado accept Medicare?

Yes. CMS data shows Dr. Grado billed Medicare for 5,382 services in 2024, and Dr. Grado accepts Medicare assignment.

Does Dr. Gordon Louis Grado offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Grado as offering telehealth services.

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Gordon Louis Grado see?

CMS counts 372 Medicare patients who saw Dr. Grado in 2024, with an average age of 76.

Is Dr. Gordon Louis Grado board certified?

Yes. Dr. Grado is board certified in radiation oncology by the American Board of Radiology.

What services does Dr. Gordon Louis Grado bill to Medicare?

In 2024, Dr. Grado's most billed Medicare services were radiation oncology (77014), medicare service (G6015) and medicare service (G2212).

Where did Dr. Gordon Louis Grado go to medical school?

Dr. Grado graduated from SIU School of Medicine in 1977.

What drugs does Dr. Gordon Louis Grado prescribe most?

In 2024 Medicare Part D data, Dr. Grado's most prescribed drugs by claims were Tamsulosin HCl, Tramadol HCl and Ciprofloxacin HCl.

Has Dr. Gordon Louis Grado received payments from drug or device companies?

CMS Open Payments shows $14,147 in general payments to Dr. Grado from 61 companies from 2016 to 2025. The largest total came from Novocure Inc.

How long has Dr. Gordon Louis Grado been practicing?

Dr. Grado graduated from medical school in 1977, 49 years ago.

Does Dr. Gordon Louis Grado do research?

Dmand AI links 11 publications to Dr. Grado. Dr. Grado has worked on 1 clinical trial.

Who does Dr. Gordon Louis Grado publish with?

Dr. Grado's most frequent co-authors are Steven Buskirk, MD (5 shared papers), Harish Gangaram Ahuja, MD (1 shared paper) and William James Maples, MD (1 shared paper).

What insurance does Dr. Gordon Louis Grado accept?

Dr. Grado is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

Selling to radiation oncology practices?

See radiation oncologists in Arizona by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)